Baseline characteristics
comorbidity
DISEASE
Median age was 60 (IQR 49–69) years, 77% were male, 72% had at least one comorbidity, 35% had received at least one dose of SARS-CoV2 vaccine, and 14% had critical disease (mechanical ventilation or ECMO) at inclusion. Systemic corticosteroids were used by 95% of participants, remdesivir by 3% and thromboprophylaxis by 90% (Table Baseline demographics and clinical characteristicsSARS-CoV2 serostatus and nasopharyngeal viral load were done in participants with biobanked samples. SARS-CoV2 serostatus was based on the anti-RBD WT (BAU/mL) value with a cut-off of 10*Values below the limit of quantification (LOQ) were replaced by the LOQ value (LOQ = 1)